Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Princeton, New Jersey 08540


Purpose:

This prospective surveillance trial will gather safety information for Optison when it is used in routine practice.


Criteria:

Inclusion Criteria: - The subject is over 18 years old. - The subject has been scheduled for an Optison-enhanced echocardiography exam. - The subject has provided signed and dated informed consent. Exclusion Criteria: - Known hypersensitivity to perflutren, blood, blood products or albumin.


NCT ID:

NCT00730964


Primary Contact:

Study Director
Rubin Sheng, MD
GE Healthcare


Backup Contact:

N/A


Location Contact:

Princeton, New Jersey 08540
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 17, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.